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Polycystic kidney syndrome in New Zealand White rabbits
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Polycystic kidney syndrome in New Zealand White rabbits re-
sembling human polycystic kidney disease.
Background. Cystic kidney diseases are an important cause
of morbidity and mortality in humans. Small animal models are
needed to more fully explore the complex expression patterns
and pathobiology of this group of heritable diseases.
Methods. We performed a 15-year retrospective analysis of
cases in our laboratory animal diagnostic archives to determine
the prevalence of cystic kidney disease in New Zealand White
rabbits.
Results. Out of 203 records with documented renal
histopathology, we identified and defined 7 cases of polycys-
tic kidney syndrome (PKS) by 3 morphologic criteria: (1) cysts
or microcysts derived from tubules, glomeruli, or both; (2) loose
mesenchymal expansion of cortical and/or medullary intersti-
tium; and (3) irregular thickening, thinning, and splitting of
basement membranes. PKS was associated with hypercalcemia
and hypercreatinemia (P < 0.01), and arterial mineralization
resembling Mo¨nckeberg’s medial calcific sclerosis. In the liver,
mild chronic cholangitis with cholangiodysplasia and fibrosis
was common. Anorexia and lethargy were the clinical signs most
often reported.
Conclusion. Clinicopathologic characterization of PKS in
New Zealand White rabbits revealed similarities to both
autosomal-dominant and autosomal-recessive polycystic kid-
ney diseases of humans. Awareness of polycystic kidney syn-
drome in New Zealand White rabbits will allow investigators
to avoid using affected animals in unrelated renal research.
Prospective studies are needed to define the underlying cause(s)
of polycystic kidney syndrome in New Zealand White rabbits,
which may be an important new small animal model of human
cystic kidney diseases.
Developmental renal diseases of humans are rela-
tively common. These include autosomal-recessive poly-
cystic kidney disease (ARPKD), autosomal-dominant
polycystic kidney disease (ADPKD), glomerulocystic
kidney disease, renal dysplasia, familial nephronophthi-
sis/medullary cystic disease, and medullary sponge kid-
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ney, among others [1–5]. Cysts are the most common re-
nal defect diagnosed in perinatal autopsies and stillborn
fetuses [6]. ADPKD is the most common cystic renal dis-
ease and occurs in ∼1 in 1000 live births [6]. Most cystic
renal diseases can eventually lead to chronic renal failure,
although clinical severity and time course are highly vari-
able [2, 7–10]. Cystic kidney diseases are associated with
other serious conditions including hypertension, extra-
renal malformations, aneurysms, and cardiac defects
[11–13].
Kidney morphogenesis is a complicated process rely-
ing on exquisitely regulated communication between the
branching ureteric bud and metanephric mesenchyme [7,
8, 14, 15]. Many genes are involved in renal development,
and mutations result in disease expression ranging in phe-
notypic severity from the subclinical to the embryoni-
cally lethal [6, 16]. Renal dysmorphogenesis commonly
results in cyst formation, and this family of diseases dis-
plays many overlapping clinical and morphologic features
that can make precise diagnosis difficult without genetic
testing [1]. In addition to kidney manifestations, ARPKD
and ADPKD are associated with liver lesions including
hepatic cysts, biliary dysgenesis, chronic cholangitis, and
portal fibrosis [1].
The New Zealand White (NZW) rabbit (Oryctolagus
cuniculus) is commonly used in biomedical research, es-
pecially for renal and cardiovascular studies. The kidney
of O. cuniculus has several unique functional and struc-
tural qualities [17]. Unlike other species, the rabbit is
absolutely dependent on the kidney for proper calcium
osmoregulation [18, 19]. The renal fractional excretion of
calcium in the rabbit is 45%, versus <2% in other mam-
mals, which eliminate excess calcium through the intesti-
nal tract [19, 20]. Healthy rabbits maintain high serum
calcium levels when compared to other species. Normal
serum calcium levels in the rabbit are 11–14 mg/dL, and
the upper limit of the normal reference range used in
some laboratories is 16 mg/dL [21]. Calcium is consti-
tutively absorbed from the rabbit gut, and dietary in-
take significantly influences serum levels in this species
[19, 22]. Because rabbits absorb calcium constitutively
and are dependent on properly functioning kidneys for
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excretion, rabbits with kidney disease or those fed di-
ets containing excessive calcium often develop hypercal-
cemia [22–25]. A common sequel to hypercalcemia in
rabbits is metastatic mineralization of blood vessels and
other soft tissues [26, 27]. In muscular arteries, mineral
deposits and scavenger cells aggregate in the tunica me-
dia, with disruption and degeneration of smooth muscle
fibers resembling Mo¨nckeberg’s medial calcific sclerosis
[28].
In contrast to humans, few cases of renal cystic dis-
eases have been reported in the rabbit. Heritable renal
cysts attributed to an autosomal-recessive mutation with
incomplete penetrance were described in the IIIvo rab-
bit strain [29]. These simple renal cysts of tubular ori-
gin were not associated with clinical signs or biochemical
abnormalities referable to renal failure [29]. Experimen-
tally, NZW rabbits given a single injection of long-acting
corticosteroids on the day of birth developed cystic re-
nal lesions and other defects including runting, muscular
atrophy, and alopecia [30]. Renal cysts attributed to uri-
nary obstruction were described in a case of idiopathic
hypercalcemia in an NZW rabbit [23]. To our knowledge,
there are no reports of spontaneous, clinically significant
cystic renal disease in unrelated rabbits.
We present in this report a retrospective analysis of
cystic kidney disease with common microscopic features
in unrelated laboratory NZW rabbits, for which we pro-
pose the name polycystic kidney syndrome (PKS). PKS
is associated with hypercalcemia and metastatic mineral-
ization of muscular arteries and other soft tissues. Clinical
signs and renal lesions in these rabbits are consistent with
developmental human cystic kidney diseases. Idiopathic
hypercalcemia is relatively common in New Zealand
White rabbits, and it is possible that PKS contributes
to this high prevalence. Familiarity with PKS may al-
low investigators to avoid confounding of results in renal
and cardiovascular research by removing affected rabbits
from animal studies. Laboratory animal production facil-
ities may identify affected rabbits and remove carriers
from the breeding pool. Finally, molecular and genetic
characterization of this syndrome in rabbits may provide
an important new small animal model of developmental
cystic kidney disease of humans.
METHODS
Animal sources and husbandry
Experimental and control rabbits were acquired from
multiple commercial sources including Hare (Hewitt, NJ,
USA), Millbrook Breeding Labs (Amherst, MA, USA),
and Covance (Denver, PA, USA). Animals were assigned
identification numbers upon arrival at the Massachusetts
Institute of Technology (MIT), and a separate Division of
Comparative Medicine, Comparative Pathology Labora-
tory, diagnostic accession number at the time of necropsy
(Table 1). All animals included in this study were main-
tained at MIT except cases #92–1438 and 01–2554, which
arrived for post-mortem evaluation from other institu-
tions. Animals tested negative for a panel of important
rabbit pathogens including Encephalitozoon cuniculi,
and were housed singly in cages with slotted floors in an
Association for Assessment and Accreditation of Labo-
ratory Animal Care (AAALAC)-accredited facility. The
environment was controlled for temperature, relative hu-
midity, light/dark cycle, and ventilation. Animals received
water and a commercial rabbit chow (Purina laboratory
rabbit diet 5321 before 1995 and diet HF 5326 after 1995;
Ralston Purina Co., St. Louis, MO, USA) ad libitum.
Case selection
Records from 1986–2002 in the MIT Division of Com-
parative Medicine, Comparative Pathology Laboratory,
archives were reviewed. Included in this study were an-
imals that had kidney lesions meeting the criteria of
PKS, animals with other significant kidney lesions and
corroborating serum chemistry data, and age-matched
control animals without kidney lesions and for which
serum chemistry data were available. Necropsies and ini-
tial histopathology were performed at MIT, and serum
was sent to commercial veterinary reference laborato-
ries for chemical analysis. Hematoxylin and eosin (H&E)
stained kidney sections were reviewed for this study by a
comparative pathologist without knowledge of case his-
tories. Based on this histopathologic review, cases were
assigned to one of three groups: (1) renal lesions consis-
tent with PKS; (2) significant renal lesions not consistent
with PKS and for which serum chemistry data were avail-
able; and (3) no signficant renal lesions, also with serum
chemistry reports.
Special stains and immunohistochemistry
Formalin-fixed, paraffin-embedded tissues were re-
trieved, cut at 5 l, and stained with H&E, Masson’s
trichrome, Congo red, periodic-acid Schiff (PAS), or
von Kossa. Microwave antigen–retrieved tissue sections
were analyzed for lectin binding by biotinylated Dolichos
biflorus (Sigma, St. Louis, MO, USA), or by immunohis-
tochemistry using primary mouse antibodies against pan-
cytokeratin (AE1/AE3; Dako, Carpinteria, CA, USA),
rabbit immunoglobulins (Dako), or vimentin (Dako), fol-
lowed by biotinylated anti-mouse immunoglobulin IgG,
using a previously described protocol [31].
Electron microscopy
Formalin-fixed kidney tissue was evaluated by trans-
mission electron microscopy (glutaraldehyde-fixed spec-
imens were not available). Tissues representing renal
cortex, corticomedullary junction, and medulla were
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Table 1. Summary of animal age, gender, and serum biochemical data in rabbits with polycystic kidney syndrome, other renal diseases, or normal
age-matched controls
Age at Total
euthanasia Creatinine Calcium Phosphorous protein Albumin Globulin
Accession number years Sex BUN mg/dL mg/dL mg/dL mg/dL g/dL g/dL g/dL
PKS
86–303 5 Female a a a a a a a
86–420 4 Female 6 3.1 19.8 1.2 a a a
92–674 2 Female 31 2.4 12.8 2.1 6.7 3.9 2.8
92–1438 2 Female 97 6.3 21.7 3.2 6.7 4.7 2.0
95–2399 2 Male a a a a a a a
01–1187 3 Female 17 2.0 19.3 4.5 5.5 4.6 0.9
01–2554 1.67 Female a a a a a a a
Mean (±SD) 2.81 (±1.26) 40.8 (± 37.8) 3.45 (±1.95)b 18.4 (± 3.9)b 2.8 (±1.4)c 6.3 (±0.7) 4.4 (±0.43)b 1.9 (±0.95)
Non-PKS kidney
disease
88–453 1 Male 25 1.6 11 6.3 5.9 3.6 2.3
88–727 1 Male 20 2.5 14.2 2.6 5.4 3.4 2.0
93–1117 5 Female 16 1.4 15.8 2.9 11.4 2.6 9.0
Mean (±SD) 2.33 (±2.31) 20.3 (±4.5) 1.8 (±0.6) 13.7 (±2.4) 3.9 (±2.1) 7.6 (±3.3) 3.2 (±0.5) 4.4 (±4.0)
Normal
87–369 2 Female 22 1.3 13.4 4.0 5.4 3.3 2.1
90–172 1.5 Female 19 1.3 14.3 2.5 5.8 3.5 2.3
93–105 2 Female 77 2.3 10.6 7.5 5.7 3.4 2.3
93–251 2.75 Female 20 1.3 14.4 3.3 6.6 4 2.6
93–285 2.75 Female 20 1.3 13.9 3.6 6.5 3.7 2.8
93–1445 5 Female 20 1.9 13.9 3.1 6.9 3.2 3.7
93–1762 3.5 Female 23 1.3 14.5 3.1 5.6 3.6 2.0
93–1763 3 Female 5 1.0 14.2 1.3 5.5 3.2 2.3
94–2055 2 Male 17 1.3 13.2 2.9 5.5 3.3 2.2
97–194 6 Female 29 1.6 12 3.8 5.9 3.3 2.6
Mean (±SD) 3.05 (±1.44) 25.2 (±19.2) 1.46 (±0.38) 13.4 (±1.2) 3.5 (±1.6) 5.94 (±0.5) 3.45 (±0.96) 2.49 (±0.63)
Reference range 5–25 0.5–2.6 5.60–12.1 4.0–6.0 5.0–7.5 2.7–5.0 1.5–2.7
aData unavailable.
bValues were significantly increased (P < 0.01) when compared to normal control animals.
cValues were below the reference range, but not significantly different from normal control animals.
post-fixed in osmium tetroxide and processed by stan-
dard techniques as previously described [32].
Statistical analysis
Statistical analyses of rabbit serum chemistry values
between groups were performed by one-way analysis of
variance (ANOVA) followed by Dunnett’s post-test us-
ing Instat 3.0 software (GraphPad, Inc., San Diego, CA,
USA). Comparisons of gender and clinical signs between
groups were assessed by Fischer exact test.
RESULTS
Case selection
Review of records archived from 1986–2002 yielded
335 total rabbit records. Of those, 132 cases were elim-
inated because no renal histopathology was performed.
Of the 203 cases in which kidney tissues were evaluated
by histopathology, there were 63 with reported lesions.
From these 63 cases we identified 7 cases of PKS which
we defined by the following 3 criteria: (1) cysts or micro-
cysts derived from tubules, glomeruli, or both; (2) loose
mesenchymal expansion of cortical and/or medullary
interstitium; and (3) irregular thickening, thinning, and
splitting of tubular and/or glomerular basement mem-
branes. Additionally, we identified 3 cases with available
serum chemistry data and significant renal lesions incon-
sistent with PKS. The remaining 53 cases were not eval-
uated further because renal lesions were mild or serum
chemistry data were unavailable. Thus, histopathologic
assessment of kidneys from 203 rabbits revealed 7 cases
of PKS (3.4%). Ten control cases were chosen based on
age-matching criteria, absence of renal lesions, and avail-
ability of serum chemistry data.
Clinical presentation
Rabbits with PKS were significantly more likely to
have a clinical history of weight loss and/or anorexia
than unaffected controls (P = 0.015). However, anorexia
and/or weight loss were equally common in rabbits with
PKS and those with other significant renal diseases (P =
1.0). Additional clinical signs recorded from some rabbits
with PKS included hematuria, lethargy, and pale mucous
membranes. One animal, case #92–1438, had a his-
tory of polyuria and polydypsia progressing to oliguria
and unthriftiness. Rabbits with PKS first demonstrated
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Fig. 1. Gross renal lesions, polycystic kidney syndrome (PKS). Pin-
point surface lesions (arrows) noted after removal of the renal capsule
(A). Cortical mineral deposits (white arrow) and microcysts (black ar-
row) at low (B) and high (C) magnification.
clinical signs at 2.9 (±1.3) years of age. Euthanasia was
performed most commonly in both PKS and other renal
disease groups due to serious illness. Gender did not ap-
pear to influence the risk for PKS when compared to
healthy controls (P = 1.0) or other renal diseases (P=
0.18); however, the preponderance of females in our over-
all study population made gender comparisons difficult
(Table 1).
Serum chemistry
Rabbits with PKS had significant hypercalcemia
(18.4 ± 3.9 mg/dL vs. 13.4 ± 1.2 in control; P < 0.01;
Table 1). Hypercreatinemia was also associated with PKS
(3.5 ± 2.0 mg/dL vs. 1.5 ± 0.4 in control; P < 0.01).
Rabbits with PKS also exhibited higher serum albumin
than control animals, although levels in both groups re-
mained within the normal reference range for the species
(Table 1) [33]. Blood urea nitrogen (BUN) was incon-
sistently elevated in rabbits with PKS; however, BUN is
an insensitive measure of renal disease in rabbits due to
circadian fluctuations, cecal microflora urea metabolism,
and other factors [34–37]. Mean serum phosphorus in
rabbits with PKS was below the lower reference limit,
and lower than control rabbits, although the difference
between groups did not reach statistical significance
(Table 1) [33]. One rabbit with PKS (#92–1438) exhibited
markedly increased levels of serum sodium (200 mEq/L),
potassium (10.9 mEq/L), and chloride (139 mEq/L) [33].
Urinalysis data were not available.
Gross lesions
Lesions identified at necropsy were highly variable
among rabbits with PKS. In many instances there were
no reported gross lesions other than decreased body fat.
Some rabbits exhibited variation in size between kidneys
that was sometimes marked. There was one case of unilat-
eral hydroureter with confirmed obstruction by a urolith;
however, the absence of severe hydronephrosis in the ip-
silateral kidney suggested that the ureteral obstruction
was incomplete or occurred shortly before euthanasia.
Although urinary calculi with renal grit (Fig. 1) and uro-
Fig. 2. Histopathology of polycystic kidney syndrome (PKS). Normal
rabbit kidney (A) versus segmentally variable lesions in kidney with
PKS (B). Three polycystic kidney syndrome–defining criteria: (1) cys-
tic or microcystic lesions affecting tubules, glomeruli, or both (C); (2)
loose mesenchymal expansion of interstitium (D); and (3) irregular
thickening (arrow), thinning, and/or splitting of basement membranes
(E). Mineralization with artifactual fissure (arrow) in tunica media of
muscular artery resembling Mo¨nckeberg’s medial calcific sclerosis (F).
Hepatic lesions associated with PKS including mild chronic cholangitis
and pericholangitis (G) and cholangiodysplasia and fibrosis (H). H&E,
hematoxylin & eosin; bar = 500 l (A, B), 100 l (C, H), 250 l (D), or
50 l (E, F, G).
cystic stones were common in the kidneys and bladder,
respectively, hydronephrosis and hydroureter were rare.
Because of the high fractional excretion of calcium in the
kidney and production of alkaline urine, calcium carbon-
ate crystals are normally present in the rabbit urinary
bladder. Grossly visible renal cysts were infrequently re-
ported, but when present were invariably confined to the
cortex and were usually <2 mm diameter. In some cases,
pinpoint surface depressions were identified following re-
moval of the renal capsule, and cortical microcysts were
barely evident on cut surface (Fig. 1). In other organs, vas-
cular mineralization resulting in rigid “pipestem” arteries
was a frequent finding in rabbits with PKS and hypercal-
cemia. Gross liver lesions were not reported.
Histopathology
Microscopic lesions in rabbits with PKS were highly
variable between animals, and even between segments
of the same kidney when compared with normal control
animals (Fig. 2A and B). Inclusion in this group, how-
ever, required that kidneys from all rabbits with PKS
meet our 3 defining histologic criteria described above
(Fig. 2C–E). Animals with glomerular cysts exhibited
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clear dilation of Bowman’s spaces up to 1 mm diame-
ter with shrinkage, atrophy, and clefting of the tuft, but
glomerular fibrosis was not marked. Bowman’s capsules
were irregularly thickened and split and sometimes lined
by plump cuboidal parietal epithelium. Dilation of con-
voluted tubules and/or collecting ducts was variable, with
attenuation of epithelium in larger cysts. Tubular lumens
contained sloughed epithelium, cellular debris, and rare
protein or waxy casts. Tubular mineralization was most
apparent in distal convoluted tubules. Segmentally, corti-
cal tubules were shrunken, lost, or disorganized. Mes-
enchymal expansion of interstitium was characterized
by a mild-to-moderate infiltrate of fibroblasts and rare
macrophages, irregular collagen formation in a loose
amorphous-to-fibrillar matrix, and widening of the space
between residual tubules. Some rabbits had multifocal,
mild-to-moderate, interstitial nephritis characterized by
infiltrates of mononuclear cells, usually most prominent
near arcuate vessels. In the medulla, loose amorphous ex-
pansion of interstitium and decreased numbers of loops
of Henle and collecting tubules and ducts were the most
common abnormalities. Renal pelvicalyces and proximal
ureters were mildly dilated or within normal limits except
in the single case of ureteral obstruction. Muscular arter-
ies in the kidney and elsewhere were disrupted by fine
mineral deposits with myofiber degeneration and infil-
tration of phagocytes in the tunica media of rabbits with
hypercalcemia (Fig. 2F). Otherwise, renal vessels were
normal except for occasional mild perivascular fibrosis;
thrombosis was not detected grossly or histologically. In
the liver there was mild but consistent chronic portal hep-
atitis characterized by small aggregates of mononuclear
leukocytes with a few granulocytes in rabbits with PKS
(Fig. 2G). Additionally, there was mild-to-moderate bile
duct duplication, ductular epithelial hyperplasia and/or
dysplasia with occasional pseudostratification, and mini-
mal pericholangiolar fibrosis (Fig. 2H).
Rabbits with significant non-PKS renal lesions and bio-
chemical evidence of renal failure included two animals
with obstructive ureteral urolithiasis resulting in classic
hydronephrosis characterized by marked renal pelvica-
lyceal dilation with compression atrophy of medullary
and deep cortical structures and dilation of persistent col-
lecting ducts. The other case involved signficant bilateral
kidney effacement by a metastatic uterine adenocarci-
noma. We identified a rabbit with evidence of multifo-
cal renal thrombosis characterized by radial streaks of
dense cortical fibrosis with mild mononuclear inflamma-
tion, tissue contraction caused by loss of affected pyramid
glomeruli and tubules, and depression of the overlying
capsule. We excluded this case from our study, however,
as there was no clinical or biochemical evidence of re-
nal insufficiency. Finally, we identified one animal with
a 5-mm diameter solitary renal cortical cyst of presump-
tive tubular origin, consistent with previous reports in
the IIIvo rabbit strain, also with no evidence of functional
impairment [29].
Special stains, lectin binding, and immunohistochemistry
PAS stain of polycystic kidneys highlighted the ir-
regular thickening, thinning, and splitting of basment
membranes observed in H&E-stained sections (Fig. 3A).
Von Kossa stain confirmed the basophilic crystalline de-
posits in distal convoluted tubules and vessels observed
in H&E-stained sections to be mineral, consistent with
dystrophic or metastatic calcification (Fig. 3B). Masson’s
trichrome stain highlighted irregular collagen deposits
in pale-staining, loose, amorphous-to-fibrillar intersti-
tial matrix (Fig. 3C). Absence of congophilia in Congo
red–stained sections confirmed that the expanded ma-
trix was not amyloid (Fig. 3D). Compared with nor-
mal control (Fig. 4A), Dolichos biflorus lectin binding
to N-acetylgalactosamine on collecting duct epithelium
demonstrated loss of collecting ducts in affected rabbit
kidneys, sometimes with irregular patchy labeling of in-
terstitium in areas of degenerating collecting ducts, pre-
sumably caused by diffusion of residual glycoconjugate
molecules (Fig. 4B). Cytokeratin staining labeled many
but not all microcystic ducts and tubules, indicating in-
volvement of both the convoluted and collecting tubu-
lar systems (Fig. 4C). Vimentin immunohistochemistry
highlighted the infiltration of fibroblasts in expanded
interstitial areas (Fig. 4D). An unexpected finding was
the marked expression of vimentin in the epithelium of
convoluted and/or collecting tubules in affected but not
normal rabbit kidneys, suggesting dedifferentiation of
tubular epithelial cells or failure of complete epithe-
lial lineage commitment during organogenesis (Fig. 4E
and F). No abnormal immunoglobulin deposits consis-
tent with immune-mediated disease were detected by im-
munohistochemistry (data not shown).
Electron microscopy
Transmission electron microscopy confirmed atrophy
and clefting of tufts in glomerulocystic lesions, as well
as periglomerular interstitial edema (Fig. 5A). Thick-
ening and splitting of glomerular basement membranes
was largely restricted to Bowman’s capsule, with rela-
tive sparing of the endothelial-podocyte basement mem-
brane complex in the tuft (Fig. 5B). Tubular basement
membranes were variably thinned or thickened, split,
and sometimes intercalated with collagen fibrils and/or
microtubule-like bodies (Fig. 5C). Interstitial cellular-
ity and matrix were highly variable, ranging from early
tubular degeneration with fibroblast expansion (Fig. 5D),
to marked tubular atrophy with fibroblastic replace-
ment (Fig. 5D), to hypocellular regions comprised al-
most entirely of irregular bundles of collagen in a loose
proteinaceous-to-fibrillar stroma (Fig. 5F).
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Fig. 3. Histochemical analysis of polycystic kidney syndrome (PKS).
Periodic-acid Schiff (PAS) stain highlights irregular thickening and
splitting of glomerular and tubular basement membranes (A). Von
Kossa stain illustrates selective mineralization of distal convoluted
tubules (B). Masson’s trichrome stain demonstrating irregular loose
and dense (arrow) fibrocollagenous expansion of interstitial stroma
(C). Absence of congophilia in Congo red–stained section rules out
amyloid deposition as the cause of mesenchymal expansion (D); note
small mononuclear leukocyte aggregate in arcuate perivascular region
(arrow). Bar = 50 l (A), 100 l (B), or 250 l (C, D).
DISCUSSION
We describe in this report a group of laboratory New
Zealand White rabbits with renal abnormalities resem-
bling human polycystic kidney diseases. This study was
prompted by the unexpected finding of dysmorphogenic
and cystic renal lesions in a rabbit submitted for necropsy
because of calcified arteries encountered during an exper-
imental surgical procedure. Lesions were variable, but al-
ways exhibited the 3 syndrome-defining criteria described
in Methods. We have proposed the term polycystic kidney
syndrome (PKS) for this disease entity in rabbits pending
elucidation of the underlying cause(s). In most instances
disease was bilateral but asymmetrical and segmentally
variable. PKS was strongly associated with hypercalcemia
and metastatic mineralization of muscular arteries and
other soft tissues. We identified PKS in ∼3% of renal
tissue specimens from our archives, suggesting that PKS
may be a significant contributor to the high prevalence
hypercalcemia in this breed [19, 21–23].
Features of PKS in New Zealand White rabbits that re-
sembled human ADPKD include involvement of the en-
tire nephron, variable penetrance and clinical expression,
onset of signs in maturity, and a relatively high prevalence
[4, 38, 39]. On the other hand, some features of PKS more
closely resembled human ARPKD, including the small
and somewhat uniform size of renal cysts, and liver le-
sions characterized by mild cholangiodysplasia, fibrosis,
and pericholangitis without hepatic cysts [1, 4, 13, 38–40].
Fig. 4. Lectin-binding and immunohistochemical analysis of polycystic
kidney syndrome (PKS). Dolichos biflorus lectin labels linearly arrayed
collecting ducts in normal rabbit kidney (A); ducts in rabbit with PKS
(B) are disorganized and decreased in number with diffuse pools of pale
staining in regions of active ductular atrophy (arrows). Mixed presence
and absence of cytokeratin labeling among dilated tubules suggests in-
volvement of both convoluted and collecting tubuloductular systems
(C). Increased vimentin-expressing mesenchymal cells in regions of ex-
panded interstitium (D). Vimentin is expressed in blood vessels and
glomerular mesangium, but not tubules, of normal rabbit (E). Aber-
rent expression of vimentin in many tubules and ducts (arrows) in rabbit
with PKS (F). Diaminobenzidine label, Gill’s hematoxylin counterstain.
Bar = 500 l (A–D) or 100 l (E, F).
Together, the mixed spectrum of lesions in rabbits with
PKS mirrors the overlapping presentation of cystic kid-
ney diseases in humans, and highlights the need for fur-
ther molecular and genetic characterization [6, 41, 42].
Additionally, some diagnostic criteria of PKS are shared
with nephrosclerosis (e.g., interstitial fibrosis and base-
ment membrane alterations), and further study will be
required to determine the potential role of renal hyper-
tension as an inducer or potentiator of cystic nephropathy
in the rabbit.
ADPKD occurs with mutations to either PKD1,
PKD2, or, rarely, PKD3 [43]. The primary PKD gene
products, polycystin-1 and polycystin-2 interact to form a
calcium-selective cation channel [44]. To date, the subcel-
lular localization and role of these proteins in the devel-
opment of ADPKD have not been completely elucidated.
Although the hypercalcemia in rabbits with PKS may be
entirely attributable to renal failure, it is also possible that
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Fig. 5. Transmission electron microscopy, polycystic kidney disease
(PKS). Glomerular atrophy (black arrow) and dilation of Bowman’s
space accompanied by periglomerular edema (white arrow; A). Irreg-
ular thickening of Bowman’s capsule with intercalated collagen fibrils
(black arrow); contrasted with more normal glomerular endothelial-
podocyte basement membrane complex (white arrow; B). Tubular base-
ment membrane alterations include thinning and splitting with interca-
lation of microtubule-like structures (black arrow) and marked amor-
phous thickening (white arrow; C). Early fibrocollagenous expansion
of cortical interstitium; note degenerating tubule (arrow) with conden-
sation of cytoplasm and loss of well-defined organelles (D). Fibroblast
hyperplasia in region of tubular atrophy (dark arrow); note relative
sparing of blood vessel (white arrow; E). Interstitial hypocellularity
with irregular collagen bundles (arrow) in a loose proteinaceous and
fibrillar matrix (F). Bar ∼ 20 l (A, D), 5 l (B, F), or 10 l (C, E).
mutations of the genes responsible for intracellular cal-
cium regulation in key cell populations may contribute to
overall serum increases of this electrolyte.
The clinical signs most commonly observed in rabbits
with PKS were anorexia and weight loss. Signs more spe-
cific to renal failure, including polydypsia and polyuria
progressing to oliguria, were not generally recorded. This
may be largely due to management and husbandry prac-
tices in modern animal care facilities. Conventionally
reared laboratory rabbits often have automatic watering
systems and are not maintained in metabolism cages for
the quantitation of daily urinary output. In such settings
it is not surprising that changes in water intake and uri-
nation would go unnoticed. Interestingly, the only rabbit
with PKS in our study that was not raised with an au-
tomated watering system was noted to have polydypsia.
Another reason why this syndrome may go unnoticed in
a research environment is because observable signs first
appear at 2 to 3 years of age. Research studies involving
rabbits are often terminated before that time. Many of
the rabbits with PKS were older rabbits used to produce
polyclonal antibodies. However, antibody production per
se did not increase the risk of PKS, as most of the unaf-
fected age-matched controls in this study were also used
to generate polyclonal antibodies.
Polycystic kidney disease has been reported in a vari-
ety of animals including mice, ferrets, rats, Persian cats,
and dogs [5, 45–51]. Indeed, the striking resemblance of
PKS to certain forms of canine familial nephropathy pro-
vides further evidence of the likely heritable nature of
this condition in rabbits [52]. The use of these animals as
models of human polycystic kidney diseases varies from
extensive, in the case of the mouse and the rat, to rare, in
the case of the dog, ferret, and cat. The rabbit compares
favorably to rodent species as a model for human poly-
cystic kidney disease. Rabbit PKS lesions and progression
closely resemble human cystic kidney diseases. Addition-
ally, NZW rabbits represent a readily available, docile,
well-characterized research animal for which a wide ar-
ray of laboratory reagents is available.
CONCLUSION
Identification of rabbits with PKS is significant for 3
reasons. First, PKS may confound research results rely-
ing on the NZW rabbit, particularly studies of the cardio-
vascular and urinary systems, and affected animals should
be identified and removed. Second, careful screening may
allow commercial rabbitries to remove animals with PKS
from the breeding pool. Finally, prospective studies with
molecular and genetic characterization of this syndrome
may produce a valuable new small animal model of hu-
man cystic kidney diseases.
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